
Pregnancy & Gynecology Drugs
Prescription drugs and medicines for conditions relating to the care of women during pregnancy and childbirth, as well as to the study of the women’s reproductive system in general. Studies in these areas include: contraception, hormone-replacement therapy, menopause, menstrual disorders, ovarian cysts, PMS, pregnancy/labor/delivery, yeast infections, and others.
The list of FDA approved drugs for obstetrics and gynecology appears below. Click any link to view the full drug information.
Number Of Pregnancy & Gynecology Drugs: 90
Combination hormone replacement therapy for the prevention of osteoporosis and other symptoms associated w/postmenopause
For the treatment of hormone receptor-positive, HER2-negative breast cancer
Treatment for the prevention of pregnancy
Transdermal patch for the prevention of postmenopausal osteoporosis and treatment of vasomotor menopausal symptoms
Treatment for osteolytic bone metastases of breast cancer
Treatment for advanced breast cancer in postmenopausal women
Exemestane Tablets, 25 mg
Oral tablet for the treatment of osteoarthritis, rheumatoid arthritis and menstrual pain
Human-derived follicle-stimulating hormone (hFSH) for use in ovulation induction for the treatment of infertility.
Treatment for relief of vasomotor symptoms due to menopause
Treatment for symptoms associated with menopause
For the prevention of cervical cancer and cervical intraepithelial neoplasia caused by HPV types 16 and 18
For the prevention of premature ovulation in women undergoing controlled ovarian stimulation
Treatment for bacterial vaginosis
Treatment for bacterial vaginosis
For the prevention of postmenopausal osteoporosis (loss of bone mass)
Treatment for infertile women with pregestone deficiency
Treatment for ovarian cancer that is refractory to other first-line therapies
For the treatment of vasomotor symptoms associated with menopause
For the emergency prevention of contraception
epirubicin hydrochloride
Treatment for symptoms associated to Menopause
Generic equivalent of Estrace
Generic equivalent of Estrace tablets
Transdermal patch system for the treatement of vulvar vaginal atrophy and vasomotor symptoms.
Treatment for the prevention of osteoporosis
For the treatment of vasomotor symptoms and vulvar and vaginal atrophy associated with menopause
Treatment for birth control
Treatment for oral contraception
Treatment to reduce renal toxicity associated with chemotherapy in subjects with advanced ovarian cancer
For the treatment of moderate to severe vasomotor symptoms due to menopause
For the treatment/prevention of osteoporosis and reduction of breast cancer risk in postmenopausal women
Osteoporosis treatment
Treatment for the prevention of osteoporosis
First-line treatment of postmenopausal women with locally advanced or metastatic breast cancer
Norethindrone acetate (1mg) and ethinyl estradiol tablets (5mcg)
Treatment for menopausal symptoms
Over the counter treatment for vaginal yeast infections
Treatment for vaginal yeast infections
Treatment for patients undergoing infertility treatments
Treatment for bacterial vaginosis
Treatment for pelvic inflammatory disease (PID)
Treatment for infertility
For the treatment of Osteoporosis in postmenopausal women and men who are at high risk for a fracture.
Treatment for osteoporosis in women after menopause and Paget's Disease of Bone
Treatment for infertility
For the treatment of metastatic breast cancer
Treatment for metastatic breast cancer
Treatment for metastatic ovarian cancer
Treatment for breast cancer prediction
Once-daily injectable treatment for bacterial infections
Treatment for endometriosis and uterine fibroids
For the treatment of heavy menstrual bleeding
For the treatment and prevention of Plasmodium falciparum malaria
Treatment for post-menopausal osteoporosis
Treatment for Hypertension
Test for breast cancer
Oral contraceptive
Hormone-releasing system for intrauterine contraception
Over the counter treatment for vaginal yeast infections
Emulsion, cream for the treatment of vaginal yeast infections
For the prevention of contraception
For the treatment of heavy menstrual bleeding
Monthly vaginal ring for birth control
Transdermal patch for contraception
Treatment for acne in women seeking contraception
17 beta estradiol/17 beta estradiol norgestimate tablets
For the induction of final follicular maturation and early luteinization in infertile women
For the first-line treatment of HER2+ metastatic breast cancer
For the prevention of postmenopausal osteoporosis and treatment of vasomotor menopause symptoms
Treatment for hormone replacement therapy
Treatment for postmenopausal hormone replacement, postmenopausal osteoporosis
Emergency Contraceptive Pills
For the treatment of postmenopausal women with osteoporosis at high risk for fracture
Treatment for amenorrhea (abnormal cessation of menses)
Treatment for Endometrial Hyperplasia
For the treatment of postmenopausal osteoporosis
For the prevention of contraception
Self-examination breast pad
Treatment for the reduction of scar tissue as a result of abdominal or pelvic surgery
Treatment for locally advanced or metastatic breast cancer
Tequin (Injectable and Tablet)
For the treatment of vaginal yeast infections
Generic equivalents of levonorgestrel and ethinyl estradiol
Treatment for moderate and severe vasomotor menopausal symptoms
For the prevention of postmenopausal osteoporosis
For the prevention of post-menopausal osteoporosis
Treatment for advanced breast cancer tumors
Oral contraceptive
Oral tablets for the treatment of premenstrual dysphoric mood disorder (PMDD)
FDA Approved Pregnancy & Gynecology Drugs Listings:
The rules of principle for evaluating MediLexicon's FDA pregnancy & gynecology drugs listings adhere to the FDA definitions of a new drug approval or a new molecular entity, and the Tufts Center for the Study of Drug Development.
MediLexicon's FDA Approved Drugs Listings include:
New Molecular Entities (NME): these NME's are described as a medication containing an active substance that have never previously approved in the US for marketing in any manner, shape or form (as defined by the FDA). In addition to this, there is also the inclusion of some FDA's Center for Drug Evaluation and Research (CDER) approved recombinant proteins and biologics.
MediLexicon's FDA Approved Drugs Listings do NOT include:
Over-the-counter products, diagnostic agents, generics, most vaccines, medical devices, biologic compounds (not approved by CDER), as well as new indications and new administrations of previously-approved compounds and new dosages.
The pregnancy & gynecology drugs information used in this section is licensed from Thomson CenterWatch. The information provided here is for general educational purposes only and does not constitute medical or pharmaceutical advice which should be sought from qualified medical and pharmaceutical advisers.



